Biblio

Export 205 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
M. Cations, Draper, B., Low, L. - F., Radford, K., Trollor, J., Brodaty, H., Sachdev, P., Gonski, P., Broe, G. Anthony, and Withall, A., “Non-Genetic Risk Factors for Degenerative and Vascular Young Onset Dementia: Results from the INSPIRED and KGOW Studies.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1747-1758, 2018.
F. J. Castora, Kerns, K. A., Pflanzer, H. K., Hitefield, N. L., Gershon, B., Shugoll, J., Shelton, M., and Coleman, R. A., “Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 90, no. 1, pp. 119-137, 2022.
C. Castillo, Bravo-Arrepol, G., Wendt, A., Saez-Orellana, F., Millar, C., Burgos, C. F., Gavilán, J., Pacheco, C., Ahumada-Rudolph, R., Napiórkowska, M., Pérez, C., Becerra, J., Fuentealba, J., and Cabrera-Pardo, J. R., “Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity.”, J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
J. M. Castellano, Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M., “Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.”, Sci Transl Med, vol. 3, no. 89, p. 89ra57, 2011.
C. - A. Castellano, Paquet, N., Dionne, I. J., Imbeault, H., Langlois, F., Croteau, E., Tremblay, S., Fortier, M., J Matte, J., Lacombe, G., Fülöp, T., Bocti, C., and Cunnane, S. C., “A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1459-1468, 2017.
R. J. Castellani and Perry, G., “Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.”, J Alzheimers Dis, vol. 67, no. 2, pp. 447-467, 2019.
R. J. Castellani, Shanes, E., McCord, M., Reish, N. J., Flanagan, M. E., Mesulam, M. - M., and Jamshidi, P., “Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report.”, J Alzheimers Dis, vol. 93, no. 2, pp. 803-813, 2023.
R. J. Castellani and Perry, G., “Dementia Pugilistica Revisited.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1209-1221, 2017.
S. Cascini, Agabiti, N., Marino, C., Acampora, A., Balducci, M., Calandrini, E., Davoli, M., and Bargagli, A. Maria, “Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.”, J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
R. Cascella, Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., and Cecchi, C., “Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.”, J Alzheimers Dis, vol. 60, no. 3, pp. 923-938, 2017.
A. Casamitjana, Petrone, P., Tucholka, A., Falcon, C., Skouras, S., Molinuevo, J. Luis, Vilaplana, V., and Gispert, J. Domingo, “MRI-Based Screening of Preclinical Alzheimer's Disease for Prevention Clinical Trials.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1099-1112, 2018.
A. Carotenuto, Rea, R., Traini, E., Fasanaro, A. Maria, Ricci, G., Manzo, V., and Amenta, F., “The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.”, J Alzheimers Dis, vol. 56, no. 2, pp. 805-815, 2017.
S. Carnemolla, Kumfor, F., Liang, C. Tao, Foxe, D., Ahmed, R., and Piguet, O., “Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 1, pp. 51-66, 2022.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., “Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
M. Carmona-Iragui, Santos, T., Videla, S., Fernández, S., Benejam, B., Videla, L., Alcolea, D., Blennow, K., Blesa, R., Lleo, A., and Fortea, J., “Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.
B. R. Cardoso, Hare, D. J., Bush, A. I., Li, Q. - X., Fowler, C. J., Masters, C. L., Martins, R. N., Ganio, K., Lothian, A., Mukherjee, S., Kapp, E. A., and Roberts, B. R., “Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).”, J Alzheimers Dis, vol. 57, no. 1, pp. 183-193, 2017.
R. Cardoso, Lemos, C., Oliveiros, B., Almeida, M. Rosário, Baldeiras, I., Pereira, C. Fragão, Santos, A., Duro, D., Vieira, D., Santana, I., and Oliveira, C. Resende, “APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 587-601, 2020.
S. Cardoso, Silva, D., Alves, L., Guerreiro, M., and de Mendonça, A., “The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
Gde Mattos Cardillo, De-Paula, Vde Jesus R., Ikenaga, E. Hiromi, Costa, L. Rodrigues, Catanozi, S., Schaeffer, E. Lisete, Gattaz, W. Farid, Kerr, D. Shikanai, and Forlenza, O. Vicente, “Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice.”, J Alzheimers Dis, vol. 63, no. 1, pp. 93-101, 2018.
N. Carcavilla, Pozo, A. Sofía, González, B., Moral-Cuesta, D., Roldán, J. Joaquín, Erice, V., and Remírez, Ade Ganuza, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
F. Carbonell, Zijdenbos, A. P., and Bedell, B. J., “Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 2, pp. 543-557, 2019.
A. W. Capuano, Wilson, R. S., Leurgans, S. E., Sampaio, C., Farfel, J. M., Barnes, L. L., and Bennett, D. A., “Relation of Literacy and Music Literacy to Dementia in Older Black and White Brazilians.”, J Alzheimers Dis, vol. 84, no. 2, pp. 737-744, 2021.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., “Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.”, J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
Q. Cao, Tan, C. - C., Xu, W., Hu, H., Cao, X. - P., Dong, Q., Tan, L., and Yu, J. - T., “The Prevalence of Dementia: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1157-1166, 2020.
X. Cao, Zhu, M., He, Y., Chu, W., Du, Y., and Du, H., “Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 2, pp. 545-552, 2018.

Pages